GlobeNewsWire · TEVA · November 11, 2026

Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6–7 Billion in Innovative Medicines Revenue by 2030

Get the app for more

Explore stock news, insights and company research.